Continuing Education

Introduction: Cardiovascular disease (CVD) is the leading cause of morbidity and mortality worldwide. Influenza infections in patients with underlying CVD

Background: Recent inpatient data abstracted from the National Inpatient Sample and/or National Readmissions Database have shown higher than expected (0.46%)

Background: Several comorbidities are known to increase the risk of coronary artery disease. However, the relationship between modifiable risk factors

Introduction: Air quality is a major environmental determinant of health, especially among adults living in areas with high levels of

Background: Atrial fibrillation (AF) affects nearly 1 million patients in VA, with morbidity and mortality disproportionately affecting racial/ethnic minorities. Anticoagulation

Introduction: In 2019, the Veterans Health Administration (VHA) began rolling out a national initiative to create a standardized mock code

Introduction: Cardiovascular Disease (CVD) is the leading cause of death in the United States. According to the Centers for Disease

Background: Targeting lower serum low-density lipoprotein cholesterol (LDL-C) levels has been a cornerstone for primary and secondary prevention of major

Background: Up to 30% of incident pericarditis patients (pts) recur within 18 months. Recurrences can be debilitating and typically last

Background: The 2019 ADA’s Standards of Medical Care in Diabetes recommend use of SGLT-2 inhibitor (SGLT-2i) or GLP-1 receptor agonist